138 related articles for article (PubMed ID: 30268824)
1. Tri-armed ligands of G-quadruplex on heteroarene-fused anthraquinone scaffolds: Design, synthesis and pre-screening of biological properties.
Tikhomirov AS; Tsvetkov VB; Kaluzhny DN; Volodina YL; Zatonsky GV; Schols D; Shchekotikhin AE
Eur J Med Chem; 2018 Nov; 159():59-73. PubMed ID: 30268824
[TBL] [Abstract][Full Text] [Related]
2. Novel multi-targeting anthra[2,3-b]thiophene-5,10-diones with guanidine-containing side chains: interaction with telomeric G-quadruplex, inhibition of telomerase and topoisomerase I and cytotoxic properties.
Ilyinsky NS; Shchyolkina AK; Borisova OF; Mamaeva OK; Zvereva MI; Azhibek DM; Livshits MA; Mitkevich VA; Balzarini J; Sinkevich YB; Luzikov YN; Dezhenkova LG; Kolotova ES; Shtil AA; Shchekotikhin AE; Kaluzhny DN
Eur J Med Chem; 2014 Oct; 85():605-14. PubMed ID: 25127152
[TBL] [Abstract][Full Text] [Related]
3. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.
Tikhomirov AS; Litvinova VA; Andreeva DV; Tsvetkov VB; Dezhenkova LG; Volodina YL; Kaluzhny DN; Treshalin ID; Schols D; Ramonova AA; Moisenovich MM; Shtil AA; Shchekotikhin AE
Eur J Med Chem; 2020 Aug; 199():112294. PubMed ID: 32428792
[TBL] [Abstract][Full Text] [Related]
4. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
[TBL] [Abstract][Full Text] [Related]
5. Development of highly predictive 3D-QSAR CoMSIA models for anthraquinone and acridone derivatives as telomerase inhibitors targeting G-quadruplex DNA telomere.
Zambre VP; Murumkar PR; Giridhar R; Yadav MR
J Mol Graph Model; 2010 Sep; 29(2):229-39. PubMed ID: 20691626
[TBL] [Abstract][Full Text] [Related]
6. Thiophene-2-carboxamide derivatives of anthraquinone: A new potent antitumor chemotype.
Volodina YL; Tikhomirov AS; Dezhenkova LG; Ramonova AA; Kononova AV; Andreeva DV; Kaluzhny DN; Schols D; Moisenovich MM; Shchekotikhin AE; Shtil AA
Eur J Med Chem; 2021 Oct; 221():113521. PubMed ID: 34082225
[TBL] [Abstract][Full Text] [Related]
7. Thiadiazole-, selenadiazole- and triazole-fused anthraquinones as G-quadruplex targeting anticancer compounds.
Andreeva DV; Vedekhina TS; Gostev AS; Dezhenkova LG; Volodina YL; Markova AA; Nguyen MT; Ivanova OM; Dolgusheva VА; Varizhuk AM; Tikhomirov AS; Shchekotikhin AE
Eur J Med Chem; 2024 Mar; 268():116222. PubMed ID: 38387333
[TBL] [Abstract][Full Text] [Related]
8. Disordering of human telomeric G-quadruplex with novel antiproliferative anthrathiophenedione.
Kaluzhny D; Ilyinsky N; Shchekotikhin A; Sinkevich Y; Tsvetkov PO; Tsvetkov V; Veselovsky A; Livshits M; Borisova O; Shtil A; Shchyolkina A
PLoS One; 2011; 6(11):e27151. PubMed ID: 22102877
[TBL] [Abstract][Full Text] [Related]
9. Tailoring a lead-like compound targeting multiple G-quadruplex structures.
Amato J; Platella C; Iachettini S; Zizza P; Musumeci D; Cosconati S; Pagano A; Novellino E; Biroccio A; Randazzo A; Pagano B; Montesarchio D
Eur J Med Chem; 2019 Feb; 163():295-306. PubMed ID: 30529547
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the Binding Insights of Novel Disubstituted Anthraquinone Derivatives with G-Quadruplex DNA to Exhibit Selective Cancer Cell Cytotoxicity.
Roy S; Muniyappa K; Bhattacharya S
ChemMedChem; 2022 Nov; 17(22):e202200436. PubMed ID: 36161519
[TBL] [Abstract][Full Text] [Related]
11. Phenanthroline-2,9-bistriazoles as selective G-quadruplex ligands.
Nielsen MC; Larsen AF; Abdikadir FH; Ulven T
Eur J Med Chem; 2014 Jan; 72():119-26. PubMed ID: 24361524
[TBL] [Abstract][Full Text] [Related]
12. Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives.
Zagotto G; Sissi C; Moro S; Dal Ben D; Parkinson GN; Fox KR; Neidle S; Palumbo M
Bioorg Med Chem; 2008 Jan; 16(1):354-61. PubMed ID: 17936629
[TBL] [Abstract][Full Text] [Related]
13. New anthra[2,3-b]furancarboxamides: A role of positioning of the carboxamide moiety in antitumor properties.
Volodina YL; Dezhenkova LG; Tikhomirov AS; Tatarskiy VV; Kaluzhny DN; Moisenovich AM; Moisenovich MM; Isagulieva AK; Shtil AA; Tsvetkov VB; Shchekotikhin AE
Eur J Med Chem; 2019 Mar; 165():31-45. PubMed ID: 30659997
[TBL] [Abstract][Full Text] [Related]
14. Discovery of the first dual G-triplex/G-quadruplex stabilizing compound: a new opportunity in the targeting of G-rich DNA structures?
Amato J; Pagano A; Cosconati S; Amendola G; Fotticchia I; Iaccarino N; Marinello J; De Magis A; Capranico G; Novellino E; Pagano B; Randazzo A
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1271-1280. PubMed ID: 27836755
[TBL] [Abstract][Full Text] [Related]
15. Screening of candidate G-quadruplex ligands for the human c-KIT promotorial region and their effects in multiple in-vitro models.
Zorzan E; Da Ros S; Musetti C; Shahidian LZ; Coelho NF; Bonsembiante F; Létard S; Gelain ME; Palumbo M; Dubreuil P; Giantin M; Sissi C; Dacasto M
Oncotarget; 2016 Apr; 7(16):21658-75. PubMed ID: 26942875
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, G-quadruplex stabilisation, docking studies, and effect on cancer cells of indolo[3,2-b]quinolines with one, two, or three basic side chains.
Lavrado J; Borralho PM; Ohnmacht SA; Castro RE; Rodrigues CM; Moreira R; dos Santos DJ; Neidle S; Paulo A
ChemMedChem; 2013 Oct; 8(10):1648-61. PubMed ID: 23960016
[TBL] [Abstract][Full Text] [Related]
17. New antitumor anthra[2,3-b]furan-3-carboxamides: Synthesis and structure-activity relationship.
Tikhomirov AS; Lin CY; Volodina YL; Dezhenkova LG; Tatarskiy VV; Schols D; Shtil AA; Kaur P; Chueh PJ; Shchekotikhin AE
Eur J Med Chem; 2018 Mar; 148():128-139. PubMed ID: 29459273
[TBL] [Abstract][Full Text] [Related]
18. Selective recognition and stabilization of new ligands targeting the potassium form of the human telomeric G-quadruplex DNA.
Lin YH; Chuang SM; Wu PC; Chen CL; Jeyachandran S; Lo SC; Huang HS; Hou MH
Sci Rep; 2016 Aug; 6():31019. PubMed ID: 27511133
[TBL] [Abstract][Full Text] [Related]
19. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
[TBL] [Abstract][Full Text] [Related]
20. Arylsulfanyl groups - Suitable side chains for 5-substituted 1,10-phenanthroline and nickel complexes as G4 ligands and telomerase inhibitors.
Liu W; Wang S; Dotsenko IA; Samoshin VV; Xue L
J Inorg Biochem; 2017 Aug; 173():12-20. PubMed ID: 28476011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
